Megan Blewett Headshot
Report a problem with this profile
[email protected]

Megan Blewett    

Associate at Venrock

Megan Blewett is the Founder of VoxHealth, a medical analytics company, and an Investment Professional at Venrock. At Venrock, Blewett works to help launch new companies in the therapeutics sector. In middle school, she became interested in finding ways to improve the treatment for autoimmune diseases. This led to her studied how a drug for multiple sclerosis worked to suppress the immune system as a Ph.D. student. In 2019, Blewett was named a Forbes 30 under 30 honoree in healthcare.


No videos yet.


Megan Blewett

Megan Blewett on the #ForbesUnder30 2019 30 Under 30 - Healthcare list.

We asked some of the top young healthcare entrepreneurs in ...

Megan Blewett, 29, is an associate at Venrock Venrock. Blewett joined healthcare and tech venture firm Venrock firm in 2017, and her areas of focus are biotech ...

Megan Blewett, Hertz Fellow, Explores Multiple Sclerosis Treatments

Despite all the advances made over the last several decades in the battle against multiple sclerosis (MS), one question that still plagues scientists is how to create drugs that can effectively target the disease without causing uncomfortable or even debilitating side effects.

Related Speakers View all

More like Megan